Longevix Biosciences

Medical Practitioner Verification

Longevix Biosciences is intended exclusively for licensed healthcare practitioners and authorized medical professionals aged 21 years or older.

By continuing you agree to our Terms & Conditions, Privacy Policy, and Shipping & Returns Policy.

About Longevix

Advancing
Precision Therapeutics

Longevix Biosciences is dedicated to providing high-quality peptide solutions aligned with modern clinical practices — bridging the gap between emerging research and evidence-informed medical application.

Brand Overview

Who We Are

Longevix Biosciences was established to address a persistent gap in the peptide therapeutics market: the absence of a clinically credible, properly documented, practitioner-only supplier operating with pharmaceutical-grade rigor.

We are not a consumer supplement brand. We are a professional distribution partner for licensed medical practitioners who demand verifiable quality, transparent documentation, and an operationally sound supply chain.

Our focus is narrow by design. We supply peptides and therapeutic compounds that are well-supported by peer-reviewed research, handled through a compliant distribution model, and accompanied by the clinical documentation practitioners need to use them responsibly.

Our Mission

To supply licensed medical professionals with the highest-quality peptide therapeutics available, supported by rigorous quality documentation and clinical-grade standards of practice.

Our Position

Practitioner-only. Non-retail. Credential-verified access. We operate at the intersection of pharmaceutical quality standards and the evolving landscape of longevity and regenerative medicine.

Our Partners

Progressive medical clinics, integrative health practices, anti-aging centers, sports medicine facilities, and licensed research institutions across the United States.

Quality Standards & Sourcing

How We Source
and Verify

Quality is not a single test — it is a chain of decisions made from raw material selection through to final product release.

01 — Raw Materials
Pharmaceutical-Grade Raw Materials

All amino acids, reagents, and solvents used in synthesis meet pharmaceutical-grade specifications. Supplier qualification includes certificate review and periodic audit.

02 — Suppliers
Verified Supplier Network

We partner exclusively with cGMP-certified manufacturing facilities. Each supplier relationship is subject to ongoing performance review and quality audit.

03 — Documentation
COA Availability

Every product is supplied with a batch-specific Certificate of Analysis generated by an independent accredited laboratory. COAs are accessible via QR code or the partner portal.

04 — Logistics
Cold-Chain Logistics

Temperature-sensitive products are shipped with validated cold-chain packaging. Overnight delivery available to ensure product integrity at point of receipt.

SPPS
Synthesis Method
Solid-Phase Peptide Synthesis — the standard for pharmaceutical peptide production
HPLC
Purity Method
High-Performance Liquid Chromatography for quantitative purity confirmation
MS
Identity Method
Mass Spectrometry for molecular weight verification and identity confirmation
LAL
Safety Method
Limulus Amebocyte Lysate test for endotoxin detection in injectable products
Manufacturing Standards

cGMP-Compliant
Manufacturing

Every Longevix product is manufactured under current Good Manufacturing Practice standards — the same regulatory framework applied to pharmaceutical production. This is not a marketing claim; it is the baseline requirement for everything we supply.

≥99%
Purity Specification
Minimum threshold enforced by HPLC on every production batch.
100%
Batch Traceability
Every vial carries a unique batch ID linked to a downloadable COA.
3rd Party
Independent Testing
Verification by accredited external laboratories — not internal QC only.
Controlled Environment Production

All synthesis and fill operations are conducted in ISO Class 7 or better cleanroom environments with continuous particulate and microbial monitoring.

  • · ISO Class 7 cleanroom standard minimum
  • · Continuous environmental monitoring
  • · Validated sterilization procedures
Batch Traceability

Every production batch is assigned a unique lot number from synthesis through to final product labeling. Any quality concern can be traced to its origin.

  • · Unique lot numbering from raw material
  • · QR-linked COA on each vial
  • · Retain samples held for 2 years post-release
Quality Assurance Protocols

Release of any batch requires passing defined analytical specifications. HPLC confirms purity; mass spectrometry confirms molecular weight; endotoxin testing confirms sterility.

  • · HPLC purity ≥99% release criterion
  • · Mass spectrometry molecular confirmation
  • · LAL endotoxin testing on injectable batches
Independent Verification

Third-Party
Testing

Internal QC is a necessary minimum — not a sufficient safeguard. Longevix employs accredited, independent analytical laboratories to perform a second, unbiased verification of every batch prior to distribution.

This dual-testing model means practitioner partners can trust the COA they receive, knowing it reflects data generated outside the manufacturing organization.

HPLC
High-Performance Liquid Chromatography
Confirms purity percentage and identifies any impurities above detection threshold.
MS
Mass Spectrometry
Verifies exact molecular weight, confirming compound identity matches the intended sequence.
LAL
Limulus Amebocyte Lysate
Detects bacterial endotoxins that could cause adverse pyrogenic reactions in injectable products.
Sample COA Highlights
Purity (HPLC)≥99.2%
Molecular Weight (MS)Confirmed
Endotoxin (LAL)<1 EU/mg
AppearanceWhite Lyophilized
Moisture Content<5%
Storage2–8°C / −20°C LT
Testing LabIndependent Accredited

Every batch we release is backed by a real, verifiable Certificate of Analysis.

Search the COA Database →
Medical Framework & Compliance

How We Operate
Within Clinical Practice

Longevix Biosciences does not sell to consumers. Our distribution model is structured around a credential-verified practitioner network, ensuring that access to our compounds is appropriately controlled.

We maintain a regulatory-aware posture — proactively monitoring FDA guidance, DEA scheduling updates, and relevant state medical board standards. This informs how we categorize, document, and distribute each compound in our portfolio.

Our Commitment

"We align with the principle that advanced therapeutics should be accessible to those who can administer them responsibly — and restricted from those who cannot."

01

Physician-Guided Usage

All products are positioned for use under direct physician supervision. We do not prescribe, diagnose, or provide individual patient guidance.

02

Protocol-Based Application

Verified partners gain access to physician-developed dosing frameworks, contraindication references, and clinical use guides developed with our advisory board.

03

Ethical Distribution Model

Credential verification is mandatory before any account activation. License number, clinic affiliation, and practitioner type are validated before wholesale access is granted.

04

Regulatory Awareness

We operate with continuous awareness of FDA guidelines, state compounding regulations, and controlled substance classifications relevant to our product portfolio.

Partnership

Work With
Longevix Biosciences

Join a network of clinical professionals who rely on Longevix for verified quality, complete documentation, and reliable supply.

Apply for Access Explore the Catalog